The Asia Pacific Aneurysm Clips Market should witness market growth of 8.1% CAGR during the forecast period (2022-2028).
Microsurgical clipping has become one of the ideal treatment methods to obstruct the intracranial aneurysm. Currently, the clinical application of the latest developed and commercially accessible titanium cerebral aneurysmal clips in treating patients with aneurysmal has displayed their biocompatibility, effectiveness to reduce clip artifacts on MRI 3-fold.
These benefits of the titanium cerebral aneurysmal clips over the conventional clips have increased their utilization in the surgery of aneurysms. Brain aneurysms could occur at any age and to anyone. Although, they are most common in adults between the years of 30 and 60 and occur more in females than in males. People with specific inherited diseases are at a higher risk of developing aneurysm.
Cerebral aneurysms could occur due to inherited risk factors, comprising genetic connective tissue diseases that weaken the artery walls, arteriovenous malformations, and polycystic kidney disease. Some AVMs grow sporadically or by themselves owing to a past aneurysm in a first-degree family member, i.e., parent, sibling, or child.
In India, studies predicted that the prevalence of stroke population lay between 116 to 163 per 100,000 people. In the recent past, the ICMR (Indian Council of Medical Research) has presented a report, “India: Health of the Nation’s States,” as per which; in 2016, stroke was the fourth leading source of death and the fifth leading cause of DALY (Disability Adjusted Life Years). With the introduction of Ayushman Bharat in 2018, it is predicted that all primary health centers and health sub-center would be upgraded as Health and Wellness Centers provide an extensive range of primary healthcare facilities. This comprises promotive, preventive, rehabilitative, and curative aspects of a broad range of facilities, including treatment for the whole population. This will lead to the growth of the aneurysm clips market in the upcoming years.
The China market dominated the Asia Pacific Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,190.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 7.4% during (2022-2028). Additionally, The India market would experience a CAGR of 8.7% during (2022-2028).
Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.
Microsurgical clipping has become one of the ideal treatment methods to obstruct the intracranial aneurysm. Currently, the clinical application of the latest developed and commercially accessible titanium cerebral aneurysmal clips in treating patients with aneurysmal has displayed their biocompatibility, effectiveness to reduce clip artifacts on MRI 3-fold.
These benefits of the titanium cerebral aneurysmal clips over the conventional clips have increased their utilization in the surgery of aneurysms. Brain aneurysms could occur at any age and to anyone. Although, they are most common in adults between the years of 30 and 60 and occur more in females than in males. People with specific inherited diseases are at a higher risk of developing aneurysm.
Cerebral aneurysms could occur due to inherited risk factors, comprising genetic connective tissue diseases that weaken the artery walls, arteriovenous malformations, and polycystic kidney disease. Some AVMs grow sporadically or by themselves owing to a past aneurysm in a first-degree family member, i.e., parent, sibling, or child.
In India, studies predicted that the prevalence of stroke population lay between 116 to 163 per 100,000 people. In the recent past, the ICMR (Indian Council of Medical Research) has presented a report, “India: Health of the Nation’s States,” as per which; in 2016, stroke was the fourth leading source of death and the fifth leading cause of DALY (Disability Adjusted Life Years). With the introduction of Ayushman Bharat in 2018, it is predicted that all primary health centers and health sub-center would be upgraded as Health and Wellness Centers provide an extensive range of primary healthcare facilities. This comprises promotive, preventive, rehabilitative, and curative aspects of a broad range of facilities, including treatment for the whole population. This will lead to the growth of the aneurysm clips market in the upcoming years.
The China market dominated the Asia Pacific Aneurysm Clips Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,190.5 Thousands by 2028. The Japan market is estimated to grow a CAGR of 7.4% during (2022-2028). Additionally, The India market would experience a CAGR of 8.7% during (2022-2028).
Based on Material, the market is segmented into Titanium Aneurysm Clips, Polymer and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers and Others. Based on Indication, the market is segmented into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Stryker Corporation, Integra LifeSciences Holdings Corporation, Boston Scientific Corporation, B. Braun Melsungen AG (Aesculap, Inc.), Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), KLS Martin Group, Adeor Medical AG, and Evonos GmbH & Co.KG.
Scope of the Study
By Material
- Titanium Aneurysm Clips
- Polymer
- Others
By End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Indication
- Stroke
- Cerebral Artery Stenosis
- Cerebral Aneurysm
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG (Aesculap, Inc.)
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- KLS Martin Group
- Adeor Medical AG
- Evonos GmbH & Co.KG
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Aneurysm Clips Market, by Material
1.4.2 Asia Pacific Aneurysm Clips Market, by End-use
1.4.3 Asia Pacific Aneurysm Clips Market, by Indication
1.4.4 Asia Pacific Aneurysm Clips Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Aneurysm Clips Market by Material
3.1 Asia Pacific Titanium Aneurysm Clips Market by Country
3.2 Asia Pacific Polymer Market by Country
3.3 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Aneurysm Clips Market by End-use
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Ambulatory Surgical Centers Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Aneurysm Clips Market by Indication
5.1 Asia Pacific Stroke Market by Country
5.2 Asia Pacific Cerebral Artery Stenosis Market by Country
5.3 Asia Pacific Cerebral Aneurysm Market by Country
5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Aneurysm Clips Market by Country
6.1 China Aneurysm Clips Market
6.1.1 China Aneurysm Clips Market by Material
6.1.2 China Aneurysm Clips Market by End-use
6.1.3 China Aneurysm Clips Market by Indication
6.2 Japan Aneurysm Clips Market
6.2.1 Japan Aneurysm Clips Market by Material
6.2.2 Japan Aneurysm Clips Market by End-use
6.2.3 Japan Aneurysm Clips Market by Indication
6.3 India Aneurysm Clips Market
6.3.1 India Aneurysm Clips Market by Material
6.3.2 India Aneurysm Clips Market by End-use
6.3.3 India Aneurysm Clips Market by Indication
6.4 South Korea Aneurysm Clips Market
6.4.1 South Korea Aneurysm Clips Market by Material
6.4.2 South Korea Aneurysm Clips Market by End-use
6.4.3 South Korea Aneurysm Clips Market by Indication
6.5 Singapore Aneurysm Clips Market
6.5.1 Singapore Aneurysm Clips Market by Material
6.5.2 Singapore Aneurysm Clips Market by End-use
6.5.3 Singapore Aneurysm Clips Market by Indication
6.6 Malaysia Aneurysm Clips Market
6.6.1 Malaysia Aneurysm Clips Market by Material
6.6.2 Malaysia Aneurysm Clips Market by End-use
6.6.3 Malaysia Aneurysm Clips Market by Indication
6.7 Rest of Asia Pacific Aneurysm Clips Market
6.7.1 Rest of Asia Pacific Aneurysm Clips Market by Material
6.7.2 Rest of Asia Pacific Aneurysm Clips Market by End-use
6.7.3 Rest of Asia Pacific Aneurysm Clips Market by Indication
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Stryker Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 B. Braun Melsungen AG (Aesculap, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.8 KLS Martin Group
7.8.1 Company Overview
7.9 Adeor Medical AG
7.9.1 Company Overview
7.10. Evonos GmbH & Co. KG
7.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Boston Scientific Corporation
- B. Braun Melsungen AG (Aesculap, Inc.)
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- KLS Martin Group
- Adeor Medical AG
- Evonos GmbH & Co.KG
Methodology
LOADING...
